For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Preclinical and clinical trial studies of drugs market:
According to our latest research, the global Preclinical and clinical trial studies of drugs market looks promising in the next 5 years. As of 2022, the global Preclinical and clinical trial studies of drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Preclinical research on new drugs refers to chemical synthesis or natural product purification research, drug analysis research, pharmacodynamics, pharmacokinetics, toxicology and pharmacy research carried out before the drug enters clinical research. a challenge and is therefore of paramount importance.
Experiments with human subjects (patients or healthy subjects) aimed at discovering or verifying the clinical medicine, pharmacology and other pharmacodynamic effects and adverse reactions of an experimental drug, or the absorption, distribution, metabolism and Excretion, to determine the efficacy and safety of drug systematic testing, known as clinical trials. Drug clinical trials are generally divided into phases I, II, III, and IV.
During the COVID-19 epidemic in 2020, drug clinical trials are facing many difficulties. The epidemic has the following impacts on drug clinical trial research: First, traffic and travel are restricted. In order to ensure the safety of subjects, hospitals and national levels are affected, and some trials are suspended. Case screening is affected, affecting progression by 3-6 months. Second, there is the issue of drug supply. Oral medications can be sent by courier. Oncology patients administered intravenously were less affected, but non-oncology patients were severely affected. May affect sample collection, resulting in missing data. Some patients could not be followed up in time, blood samples were missing, and continuous data was missing, which affected the quality of the trial. In some clinical trials, in addition to key indicators, there are some alternative indicators that cannot be collected, patients are not followed up in hospitals in a timely manner, and later statistics will affect the quality and results of the trials. Third, during the trial, the subjects had to withdraw from the trial for various reasons. Fourth, because the influence has already been produced, the research results are biased, and the statistics and test structure need to be adjusted.
From germination to commercial sales, a new drug needs to go through four stages: drug discovery, preclinical research, clinical research, and marketing approval. Therefore, new drug research and development has three major pain points: long research and development cycle, high research and development costs, and high research and development risks. The trend of new drug research and development has brought out a more immediate problem, which is the competition for limited clinical resources. On the one hand, the number of clinical bases is insufficient. At present, public hospitals do not take clinical research as an important indicator for evaluating tertiary hospitals, and the number of clinical trial bases in my country is insufficient. Another aspect is the lack of innovative clinical research capabilities. In the early days of the development of the pharmaceutical industry, the focus was on generic drugs, and little emphasis was placed on the development of new drugs. Most hospitals did not have the technology to conduct clinical trials of innovative drugs. According to industry experts, China's lack of clinical research capabilities and resources, if not resolved in time, will delay the development of China's innovative drug industry by at least 5 to 10 years. It is understood that the development of new drugs is a long and complicated process, in which clinical trials are a very time-consuming and costly stage in the development of new drugs, and there are often many uncertainties in clinical trials.
Company Overview:
Wuxi PharmaTech New Drug Development Co., Ltd.
2022.07.19-WuXi AppTec announced plans to establish a R&D and production base in Singapore, and expects to invest a total of S$2 billion (approximately US$1.43 billion) in the construction of the new base in the next ten years, so as to better serve global cooperation Partner empowerment continuously accelerates the process of medical innovation and benefits patients around the world. The total amount of investment will be invested in stages within the next 10 years according to the company's business development needs.
Hangzhou Tigermed Pharmaceutical Technology Co., Ltd.
2023.01.19-Industry-leading integrated biomedicine and medical device R&D service platform: Hangzhou Tigermed announced the completion of the acquisition of Marti Farm, a European CRO company. Marti Farm is a European clinical contract research organization headquartered in Croatia, providing clinical development consulting services and solutions to the healthcare, pharmaceutical and food industries.
Segmentation Overview:
By type, Pharmacokinetic study of new drugs segment accounted for the largest share of market in 2022.
Application Overview:
By application, the clinical trial stage segment occupied the biggest share from 2018 to 2022.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Preclinical and clinical trial studies of drugs market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Preclinical and clinical trial studies of drugs Market Report:
Market Size Estimates: Preclinical and clinical trial studies of drugs market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Preclinical and clinical trial studies of drugs market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Preclinical and clinical trial studies of drugs market
Segment Market Analysis: Preclinical and clinical trial studies of drugs market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Preclinical and clinical trial studies of drugs market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Preclinical and clinical trial studies of drugs Market: Revenue and sales volume of major countries in each region
Preclinical and clinical trial studies of drugs Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Preclinical and clinical trial studies of drugs market in major regions.
Preclinical and clinical trial studies of drugs Industry Value Chain: Preclinical and clinical trial studies of drugs market raw materials & suppliers, manufacturing process, distributors, downstream customers
Preclinical and clinical trial studies of drugs Industry News, Policies & Regulations
Key players in the global Preclinical and clinical trial studies of drugs market are covered in Chapter 12:
Charles River
IQVIA
Hangzhou Tigermed Pharmaceutical Technology Co., Ltd.
Parexel
Shanghai Xihua Testing Technology Service Co., Ltd.
Labcorp
Chongqing Denali Pharmaceutical Technology Co., Ltd.
Pharmaron Chemicals (Beijing) New Drug Technology Co., Ltd.
Ningbo Xining Testing Technology Co., Ltd.
Beijing Sunshine Novo Pharmaceutical Research Co., Ltd.
Northridge (Beijing) Pharmaceutical Technology Co., Ltd.
Wuhan Hongren Biomedical Co., Ltd.
Junke Zhengyuan (Beijing) Drug Research Co., Ltd.
Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.
Wuxi PharmaTech New Drug Development Co., Ltd.
In Chapter 2 and Chapter 15.1, based on types, the Preclinical and clinical trial studies of drugs market from 2018 to 2028 is primarily split into:
Pharmacokinetic study of new drugs
New Drug Immunogenicity Research
New drug biomarker research
Bioequivalence Study of Generic Drugs
In Chapter 3 and Chapter 15.2, based on applications, the Preclinical and clinical trial studies of drugs market from 2018 to 2028 covers:
preclinical research stage
clinical trial stage
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Preclinical and clinical trial studies of drugs market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028